380 related articles for article (PubMed ID: 30115047)
1. Development of a core outcome set for therapeutic clinical trials enrolling dogs with atopic dermatitis (COSCAD'18).
Olivry T; Bensignor E; Favrot C; Griffin CE; Hill PB; Mueller RS; Plant JD; Williams HC;
BMC Vet Res; 2018 Aug; 14(1):238. PubMed ID: 30115047
[TBL] [Abstract][Full Text] [Related]
2. Validation of the Canine Atopic Dermatitis Extent and Severity Index (CADESI)-4, a simplified severity scale for assessing skin lesions of atopic dermatitis in dogs.
Olivry T; Saridomichelakis M; Nuttall T; Bensignor E; Griffin CE; Hill PB;
Vet Dermatol; 2014 Apr; 25(2):77-85, e25. PubMed ID: 24461108
[TBL] [Abstract][Full Text] [Related]
3. Validation of CADESI-03, a severity scale for clinical trials enrolling dogs with atopic dermatitis.
Olivry T; Marsella R; Iwasaki T; Mueller R;
Vet Dermatol; 2007 Apr; 18(2):78-86. PubMed ID: 17355421
[TBL] [Abstract][Full Text] [Related]
4. Successful nutritional control of scratching and clinical signs associated with adverse food reaction: A randomized controlled COSCAD'18 adherent clinical trial in dogs in the United Kingdom.
Weemhoff JL; MacLeay JM; Brejda J; Schiefelbein H; Wernimont SM; Gross KL
J Vet Intern Med; 2021 Jul; 35(4):1893-1901. PubMed ID: 34114684
[TBL] [Abstract][Full Text] [Related]
5. Successful nutritional control of scratching and clinical signs associated with adverse food reaction: A randomized controlled COSCAD'18 adherent clinical trial in dogs in the United States.
Weemhoff JL; MacLeay JM; Brejda J; Schiefelbein H; Wernimont SM; Gross KL
J Vet Intern Med; 2021 Jul; 35(4):1884-1892. PubMed ID: 34114677
[TBL] [Abstract][Full Text] [Related]
6. Determination of CADESI-03 thresholds for increasing severity levels of canine atopic dermatitis.
Olivry T; Mueller R; Nuttall T; Favrot C; Prélaud P;
Vet Dermatol; 2008 Jun; 19(3):115-9. PubMed ID: 18477326
[TBL] [Abstract][Full Text] [Related]
7. Development and validation of the Canine Atopic Dermatitis Lesion Index, a scale for the rapid scoring of lesion severity in canine atopic dermatitis.
Plant JD; Gortel K; Kovalik M; Polissar NL; Neradilek MB
Vet Dermatol; 2012 Dec; 23(6):515-e103. PubMed ID: 23140318
[TBL] [Abstract][Full Text] [Related]
8. Cyclosporine decreases skin lesions and pruritus in dogs with atopic dermatitis: a blinded randomized prednisolone-controlled trial.
Olivry T; Rivierre C; Jackson HA; Murphy KM; Davidson G; Sousa CA
Vet Dermatol; 2002 Apr; 13(2):77-87. PubMed ID: 11972891
[TBL] [Abstract][Full Text] [Related]
9. Pilot evaluation of the antipruritic efficacy of a topical transient receptor potential melastatin subfamily 8 (TRPM8) agonist in dogs with atopic dermatitis and pedal pruritus.
Tamamoto-Mochizuki C; Murphy KM; Olivry T
Vet Dermatol; 2018 Feb; 29(1):29-e14. PubMed ID: 28952176
[TBL] [Abstract][Full Text] [Related]
10. A randomised controlled trial testing the rebound-preventing benefit of four days of prednisolone during the induction of oclacitinib therapy in dogs with atopic dermatitis.
Olivry T; Lokianskiene V; Blanco A; Mestre PD; Bergvall K; Beco L
Vet Dermatol; 2023 Apr; 34(2):99-106. PubMed ID: 36330780
[TBL] [Abstract][Full Text] [Related]
11. Non-controlled, open-label clinical trial to assess the effectiveness of a dietetic food on pruritus and dermatologic scoring in atopic dogs.
Witzel-Rollins A; Murphy M; Becvarova I; Werre SR; Cadiergues MC; Meyer H
BMC Vet Res; 2019 Jun; 15(1):220. PubMed ID: 31253166
[TBL] [Abstract][Full Text] [Related]
12. A blinded, randomized clinical trial comparing the efficacy and safety of oclacitinib and ciclosporin for the control of atopic dermatitis in client-owned dogs.
Little PR; King VL; Davis KR; Cosgrove SB; Stegemann MR
Vet Dermatol; 2015 Feb; 26(1):23-30, e7-8. PubMed ID: 25496303
[TBL] [Abstract][Full Text] [Related]
13. Efficacy of ultra-micronized palmitoylethanolamide in canine atopic dermatitis: an open-label multi-centre study.
Noli C; Della Valle MF; Miolo A; Medori C; Schievano C;
Vet Dermatol; 2015 Dec; 26(6):432-40, e101. PubMed ID: 26283633
[TBL] [Abstract][Full Text] [Related]
14. Development and validation of a graphic 2D investigator's global assessment instrument for grading the overall severity of atopic dermatitis in dogs.
High EJ; Olivry T
Vet Dermatol; 2020 Jun; 31(3):207-e43. PubMed ID: 31833143
[TBL] [Abstract][Full Text] [Related]
15. Efficacy of oclacitinib (Apoquel®) compared with prednisolone for the control of pruritus and clinical signs associated with allergic dermatitis in client-owned dogs in Australia.
Gadeyne C; Little P; King VL; Edwards N; Davis K; Stegemann MR
Vet Dermatol; 2014 Dec; 25(6):512-8, e86. PubMed ID: 25109820
[TBL] [Abstract][Full Text] [Related]
16. Long-term compassionate use of oclacitinib in dogs with atopic and allergic skin disease: safety, efficacy and quality of life.
Cosgrove SB; Cleaver DM; King VL; Gilmer AR; Daniels AE; Wren JA; Stegemann MR
Vet Dermatol; 2015 Jun; 26(3):171-9, e35. PubMed ID: 25688708
[TBL] [Abstract][Full Text] [Related]
17. Randomized controlled trial of the efficacy of cyclosporine in the treatment of atopic dermatitis in dogs.
Olivry T; Steffan J; Fisch RD; Prélaud P; Guaguère E; Fontaine J; Carlotti DN;
J Am Vet Med Assoc; 2002 Aug; 221(3):370-7. PubMed ID: 12164533
[TBL] [Abstract][Full Text] [Related]
18. Clinical efficacy of low-level laser therapy on localized canine atopic dermatitis severity score and localized pruritic visual analog score in pedal pruritus due to canine atopic dermatitis.
Stich AN; Rosenkrantz WS; Griffin CE
Vet Dermatol; 2014 Oct; 25(5):464-e74. PubMed ID: 24909192
[TBL] [Abstract][Full Text] [Related]
19. Efficacy and safety of oclacitinib for the control of pruritus and associated skin lesions in dogs with canine allergic dermatitis.
Cosgrove SB; Wren JA; Cleaver DM; Martin DD; Walsh KF; Harfst JA; Follis SL; King VL; Boucher JF; Stegemann MR
Vet Dermatol; 2013 Oct; 24(5):479-e114. PubMed ID: 23829933
[TBL] [Abstract][Full Text] [Related]
20. Allogeneic adipose-derived mesenchymal stem cell therapy in dogs with refractory atopic dermatitis: clinical efficacy and safety.
Villatoro AJ; Hermida-Prieto M; Fernández V; Fariñas F; Alcoholado C; Rodríguez-García MI; Mariñas-Pardo L; Becerra J
Vet Rec; 2018 Dec; 183(21):654. PubMed ID: 30158120
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
